Chipmakers Capitalizing On Intel's Pivot
Intel is undergoing a major restructuring, including significant layoffs and scaling back investments in new chip factories. This strategic pivot could create opportunities for its competitors to capture market share and expand their own manufacturing capabilities.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
Intel's major restructuring, including 15% workforce cuts and canceled factory investments, creates a significant opportunity in the semiconductor market. When a dominant player contracts, it often opens doors for competitors to capture market share, talent, and production capacity that was previously locked up.
What You Need to Know
This group spans the entire semiconductor ecosystem - from chip designers and manufacturers to foundries and equipment suppliers. It's an event-driven investment theme that focuses on companies positioned to benefit from Intel's strategic pullback and the resulting market dynamics.
Why These Stocks
These companies were handpicked by professional analysts as the most likely beneficiaries of Intel's pivot. They include direct competitors who can absorb market demand, foundries that can take on additional production, and equipment suppliers who may see increased orders as rivals expand operations.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+17.45%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 17.45% over the next year.
Stocks Rated Buy by Analysts
13 of 17 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Market Share Up for Grabs
Intel's workforce cuts and canceled investments create a rare opportunity for competitors to capture significant market share. When a major player steps back, the winners often emerge quickly.
Talent and Capacity Shift
With 15% of Intel's workforce being let go, rival companies can attract top semiconductor talent while also absorbing production capacity that's becoming available.
Equipment Suppliers Win Too
As Intel's competitors expand to fill the gap, companies that make semiconductor manufacturing equipment and materials could see a surge in new orders and contracts.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.